The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Greetings, colleagues!
.jpg?sfvrsn=2aad2fbd_1 "Meghan Delaney head shot july 2022 (002)")
The AABB Annual Meeting has been a cornerstone of my professional journey. As I reflect on my career, I can trace nearly every milestone and professional achievement to connections or insights gained through this event. Every year, I look forward to attending the AABB Annual Meeting with anticipation and excitement. There’s always something valuable in store for attendees—from education sessions, to focused networking events, to new learning opportunities, and much more. One highlight for me is reconnecting with long-time colleagues and meeting new faces. The experience fills my cup, and I always leave feeling inspired for the year ahead.
Because we pour so much of ourselves into our work, it’s important to take time to recharge, show up for ourselves and support one another. During the 2025 AABB Annual Meeting in San Diego, attendees will have myriad opportunities to celebrate their colleagues' accomplishments, sharpen their knowledge and discuss issues pertinent to the field of transfusion medicine and biotherapies in a safe, collaborative space. The exchange of knowledge within our global community will inspire you, challenge you and spark new ideas.
This issue of AABB News focuses on the technology that is helping to advance transfusion medicine and biotherapies. In the first feature, researchers explore the practical application of machine learning or other artificial intelligence algorithms being applied to transfusion prediction. The second article examines the impact of virtual reality in transfusion training, highlighting the United Kingdom’s NHS Blood and Transplant’s (NHSBT) innovative blood identification and crossmatching apps. In the third feature, two blood centers discuss the evolution of technology and how artificial intelligence is reshaping donor recruitment strategies.
In addition, this issue features an interview with Steven Armstrong, DHA, MT(AMT), SBB(ASCP), FACHE, chair of AABB’s Annual Meeting Education Committee. Read the article to learn more about this year's highlights and what attendees can expect from the event. I urge you to register by July 30 to save up to $300 on regular-rate, full-meeting registration and gain early access to hotels and events.
I’d truly love to hear your thoughts about the Annual Meeting. Feel free to drop me a line at president@aabb.org. I look forward to seeing you in San Diego!
.jpg?sfvrsn=ba2dc62c_1 "M Delaney Electronic Signature file (002)")
Meghan Delaney, DO, MPH
AABB President
PREVIOUS STORY
AI Makes Early Inroads for Transfusion PredictionBACK TO ISSUE
July 2025
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.
©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies
Web Design and Development by Matrix Group International, Inc.
